Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
VUNO PRESENTS CUTTING-EDGE AI BRAIN TECHNOLOGY AT AAIC - ANALYZING MRI SCANS IN <1 MINUTE TO SUPPORT DIAGNOSIS OF ALZHEIMER'S DISEASE 2024-06-19 14:14
LD Carbon Closes $28M Investment to Scale Production of Sustainable Carbon Black and Pyrolysis Oil 2024-06-19 06:00
Nota AI®, Leading AI Optimization Company, Secures $19.9 Million Series C Funding to Pioneer On-Device Generative AI 2024-06-18 21:00
QS Names the World's Best Student Cities 2024-06-18 18:00
STRADVISION Receives 'NextRise 2024 Global Innovator' Award 2024-06-17 23:00
Noul Participates in a Malaria Project Initiated by U.S. CDC with Kenya Medical Research Institute 2024-06-17 21:00
GANGNAM glow's new sunscreen 'increased sales by 236% on Amazon in North America' within a month of launch, earned favorable reviews for its refreshing feel and high-efficacy ingredients 2024-06-13 10:10
SEMIFIVE Collaborates with OPENEDGES on Chiplet Development 2024-06-13 06:00
EDINT to showcase Proctormatic, a mobile-based AI online proctoring service at ISTE 2024 2024-06-12 23:00
Air Premia purchases spare engine to enhance operational stability 2024-06-12 22:00
SEMIFIVE joins Arm Total Design with plans to develop Arm Neoverse-powered HPC Platform 2024-06-12 06:00
Hyundai Mobis Unveils Future of In-Vehicle Display with 'Moving Panoramic Screens' 2024-06-11 20:00
ITC final initial determination Ruled in favor of Hugel (no violation of Section 337) 2024-06-11 11:33
"The Best Opportunity to Experience K-Fashion": MUSINSA Hosts 'MONSTER SALE,' Its Biggest Summer Promotion, for Two Weeks 2024-06-10 21:00
Amorepacific Appoints Giovanni Valentini as CEO for the North America Region 2024-06-10 21:00
LG Innotek solidifying its position as a leader in camera modules through innovative AI processes 2024-06-10 20:00
FDA Grants Fast Track Designation to GCBP and Novel Pharma's GC1130A 2024-06-10 16:18
J INTS BIO, ASCO 2024 - JIN-A02 showed tumor reductions including brain metastasis in the ongoing first-in-human, dose-finding Phase 1 clinical study 2024-06-10 13:56
DeepQure receives IDE Approval from FDA for its EFS study to treat Resistant Hypertension with its Extravascular Renal Denervation Technology (HyperQure™) 2024-06-10 13:14
Amorepacific Hosts NBRI Symposium 2024-06-07 21:00
1 11 12 13 14 15 160